BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11213898)

  • 21. Molecular biology of type 1 (insulin-dependent) diabetes mellitus.
    Lernmark A
    Diabetologia; 1985 Apr; 28(4):195-203. PubMed ID: 3160627
    [No Abstract]   [Full Text] [Related]  

  • 22. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
    Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited.
    Harrison LC
    Immunol Today; 1992 Sep; 13(9):348-52. PubMed ID: 1466752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cytoplasmic islet cell antibodies and GAD antibodies in diagnosis of diabetes].
    Bieg S; Seissler J; Scherbaum WA
    Med Klin (Munich); 1995 Oct; 90(10):594-8. PubMed ID: 7500923
    [No Abstract]   [Full Text] [Related]  

  • 25. Short-term exclusive breastfeeding predisposes young children with increased genetic risk of Type I diabetes to progressive beta-cell autoimmunity.
    Kimpimäki T; Erkkola M; Korhonen S; Kupila A; Virtanen SM; Ilonen J; Simell O; Knip M
    Diabetologia; 2001 Jan; 44(1):63-9. PubMed ID: 11206413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies.
    Franke B; Galloway TS; Wilkin TJ
    Diabetes Metab Res Rev; 2005; 21(5):395-415. PubMed ID: 15895384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous onset of type 1 diabetes in monozygotic twins younger than 1 year.
    Uchida N; Amano Y; Akazawa Y; Nakamura S; Minami I; Washizawa K; Wakabayashi Y; Yasui K
    Eur J Pediatr; 2008 Feb; 167(2):161-3. PubMed ID: 17361417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.
    Fukui M; Nakamura N; Nakano K; Kondo M
    Diabetes Care; 1999 Oct; 22(10):1758-9. PubMed ID: 10526760
    [No Abstract]   [Full Text] [Related]  

  • 29. [Early detection of autoimmune diabetes mellitus].
    Amital-Teplizki H; Shoenfeld Y
    Harefuah; 1994 Feb; 126(4):211-4. PubMed ID: 8168767
    [No Abstract]   [Full Text] [Related]  

  • 30. What is the best way to predict IDDM?
    Palmer JP
    Lancet; 1994 Jun; 343(8910):1377-8. PubMed ID: 7910879
    [No Abstract]   [Full Text] [Related]  

  • 31. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.
    Giannopoulou EZ; Winkler C; Chmiel R; Matzke C; Scholz M; Beyerlein A; Achenbach P; Bonifacio E; Ziegler AG
    Diabetologia; 2015 Oct; 58(10):2317-23. PubMed ID: 26138334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three cases of GAD65 antibody-positive diabetes with ketosis and abrupt onset resulting in non-insulin-dependent state.
    Morimoto J; Maruyama T; Kasuga A; Ozawa Y; Kobayashi A; Funakoshi S; Iwasaki R; Suzuki Y; Shimada A; Saruta T
    Diabetes Care; 1998 Nov; 21(11):2037-9. PubMed ID: 9802771
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunogenetic mechanisms in the pathogenesis of type 1 diabetes mellitus].
    Tatoń J; Czech A; Podgórski G
    Pol Tyg Lek; 1984 Aug; 39(34):1141-6. PubMed ID: 6390380
    [No Abstract]   [Full Text] [Related]  

  • 34. HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group.
    Veijola R; Reijonen H; Vähäsalo P; Sabbah E; Kulmala P; Ilonen J; Akerblom HK; Knip M
    J Clin Invest; 1996 Dec; 98(11):2489-95. PubMed ID: 8958211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic risk determines the emergence of diabetes-associated autoantibodies in young children.
    Kupila A; Keskinen P; Simell T; Erkkilä S; Arvilommi P; Korhonen S; Kimpimäki T; Sjöroos M; Ronkainen M; Ilonen J; Knip M; Simell O
    Diabetes; 2002 Mar; 51(3):646-51. PubMed ID: 11872662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Difference between islet cell antibodies and autoantibodies to glutamic acid decarboxylase-containing Purkinje cells in IDDM.
    Kobayashi T; Nakanishi K; Murase T; Kosaka K
    Diabetes Care; 1992 Oct; 15(10):1435-6. PubMed ID: 1425115
    [No Abstract]   [Full Text] [Related]  

  • 37. Stability of autoantibodies and their relation to genetic and metabolic markers of Type I diabetes in initially unaffected schoolchildren.
    Kulmala P; Rahko J; Savola K; Vähäsalo P; Veijola R; Sjöroos M; Reunanen A; Ilonen J; Knip M
    Diabetologia; 2000 Apr; 43(4):457-64. PubMed ID: 10819239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Islet autoantibodies in cord blood from children who developed type I (insulin-dependent) diabetes mellitus before 15 years of age.
    Lindberg B; Ivarsson SA; Landin-Olsson M; Sundkvist G; Svanberg L; Lernmark A
    Diabetologia; 1999 Feb; 42(2):181-7. PubMed ID: 10064098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of GAD65 and IA-2 autoantibodies in IDDM patients affected by diabetic nephropathy.
    Zerbini G; Bazzigaluppi E; Mangili R; Bosi E; Bonifacio E
    Diabetologia; 1997 Apr; 40(4):485. PubMed ID: 9112029
    [No Abstract]   [Full Text] [Related]  

  • 40. Congenital autoimmune diabetes mellitus.
    Cilio CM; Bosco S; Moretti C; Farilla L; Savignoni F; Colarizi P; Multari G; Di Mario U; Bucci G; Dotta F
    N Engl J Med; 2000 May; 342(20):1529-31. PubMed ID: 10819656
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.